TAS-203, an oral phosphodiesterase 4 inhibitor, exerts anti-inflammatory activities in a rat airway inflammation model

European Journal of Pharmacology ◽

10.1016/j.ejphar.2019.01.068 ◽

2019 ◽

Vol 849 ◽

pp. 22-29 ◽

Cited By ~ 2

Author(s):

Shunsuke Demizu ◽

Naomasa Asaka ◽

Hiroyuki Kawahara ◽

Eiji Sasaki

Keyword(s):

Airway Inflammation ◽

Phosphodiesterase 4 ◽

Inflammation Model ◽

Anti Inflammatory ◽

Phosphodiesterase 4 Inhibitor

Download Full-text

CHF6001 I: A Novel Highly Potent and Selective Phosphodiesterase 4 Inhibitor with Robust Anti-Inflammatory Activity and Suitable for Topical Pulmonary Administration

Journal of Pharmacology and Experimental Therapeutics ◽

10.1124/jpet.114.220541 ◽

2015 ◽

Vol 352 (3) ◽

pp. 559-567 ◽

Cited By ~ 40

Author(s):

Nadia Moretto ◽

Paola Caruso ◽

Raffaella Bosco ◽

Gessica Marchini ◽

Fiorella Pastore ◽

...

Keyword(s):

Inflammatory Activity ◽

Pulmonary Administration ◽

Phosphodiesterase 4 ◽

Anti Inflammatory ◽

Phosphodiesterase 4 Inhibitor

Download Full-text

A Novel Nonsteroidal, Topical Anti-inflammatory, Phosphodiesterase 4 Inhibitor, Crisaborole Ointment, Reduced Pruritus and Signs of Atopic Dermatitis in 2 Phase 3 Studies in Children and Adults

10.1542/peds.141.1_meetingabstract.251 ◽

2018 ◽

Author(s):

Adelaide A. Hebert ◽

Lawrence F. Eichenfield ◽

Mark G. Lebwohl ◽

Amy S. Paller ◽

Eric L. Simpson ◽

...

Keyword(s):

Atopic Dermatitis ◽

Phase 3 ◽

Phosphodiesterase 4 ◽

Anti Inflammatory ◽

Phosphodiesterase 4 Inhibitor

Download Full-text

SAT-356-Anti-metabolic, anti-inflammatory and anti-fibrotic properties of ART-, a novel phosphodiesterase 4 inhibitor as a potential clinical candidate for non-alcoholic steatohepatitis

Journal of Hepatology ◽

10.1016/s0618-8278(19)31586-5 ◽

2019 ◽

Vol 70 (1) ◽

pp. e796

Author(s):

Yuichiro Amano ◽

Shuntarou Tsuchiya ◽

Mitsuharu Matsumoto ◽

Hikaru Ueno ◽

Nobuhiro Nishigaki ◽

...

Keyword(s):

Phosphodiesterase 4 ◽

Alcoholic Steatohepatitis ◽

Anti Inflammatory ◽

Phosphodiesterase 4 Inhibitor ◽

Clinical Candidate

Download Full-text

Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy

Proceedings for Annual Meeting of The Japanese Pharmacological Society ◽

10.1254/jpssuppl.93.0_2-o-070 ◽

2020 ◽

Vol 93 (0) ◽

pp. 2-O-070

Author(s):

Yasunori Nio ◽

Masayuki Tanaka ◽

Yoshihiko Hirozane ◽

Yo Muraki ◽

Takanori Matsuo ◽

...

Keyword(s):

Duchenne Muscular Dystrophy ◽

Muscular Dystrophy ◽

Combination Therapy ◽

Mdx Mice ◽

Phosphodiesterase 5 Inhibitor ◽

Phosphodiesterase 4 ◽

Anti Inflammatory ◽

Phosphodiesterase 5 ◽

Phosphodiesterase 4 Inhibitor ◽

Inhibitor Combination

Download Full-text

CHF6001 II: A Novel Phosphodiesterase 4 Inhibitor, Suitable for Topical Pulmonary Administration—In Vivo Preclinical Pharmacology Profile Defines a Potent Anti-Inflammatory Compound with a Wide Therapeutic Window

Journal of Pharmacology and Experimental Therapeutics ◽

10.1124/jpet.114.220558 ◽

2015 ◽

Vol 352 (3) ◽

pp. 568-578 ◽

Cited By ~ 26

Author(s):

Gino Villetti ◽

Chiara Carnini ◽

Loredana Battipaglia ◽

Laurent Preynat ◽

Pier Tonino Bolzoni ◽

...

Keyword(s):

Therapeutic Window ◽

Pulmonary Administration ◽

Phosphodiesterase 4 ◽

Preclinical Pharmacology ◽

Anti Inflammatory ◽

Phosphodiesterase 4 Inhibitor

Download Full-text

Faculty Opinions recommendation of Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.719848696.793517124 ◽

2016 ◽

Author(s):

Kamran Ghoreschi

Keyword(s):

Inflammatory Activity ◽

Camp Phosphodiesterase ◽

Phosphodiesterase 4 ◽

Anti Inflammatory ◽

Phosphodiesterase 4 Inhibitor

Download Full-text

Phase 3 Studies Treating Children and Adult Patients with Mild to Moderate Atopic Dermatitis with Crisaborole Ointment, a Novel, Nonsteroidal, Topical Anti-inflammatory, Phosphodiesterase 4 Inhibitor

10.1542/peds.141.1_meetingabstract.275 ◽

2018 ◽

Author(s):

Amy S. Paller ◽

Wynnis L. Tom ◽

Mark G. Lebwohl ◽

Mark Boguniewicz ◽

Lawrence F. Eichenfield ◽

...

Keyword(s):

Atopic Dermatitis ◽

Adult Patients ◽

Phase 3 ◽

Phosphodiesterase 4 ◽

Anti Inflammatory ◽

Phosphodiesterase 4 Inhibitor

Download Full-text

Clinical anti-inflammatory efficacy of arofylline, a new selective phosphodiesterase-4 inhibitor, in dogs with atopic dermatitis

Veterinary Record ◽

10.1136/vr.145.7.191 ◽

1999 ◽

Vol 145 (7) ◽

pp. 191-194 ◽

Cited By ~ 25

Author(s):

L. Ferrer ◽

J. Alberola ◽

M. Queralt ◽

P. Brazis ◽

R. Rabanal ◽

...

Keyword(s):

Atopic Dermatitis ◽

Phosphodiesterase 4 ◽

Anti Inflammatory ◽

Phosphodiesterase 4 Inhibitor

Download Full-text

Effects of the new benzimidazole derivative TAS-203, an orally active phosphodiesterase 4 inhibitor, on airway inflammation in rats and emetic responses in ferrets

Arzneimittelforschung ◽

10.1055/s-0031-1296326 ◽

2011 ◽

Vol 60 (09) ◽

pp. 564-570

Author(s):

Naomasa Asaka ◽

Hiroyuki Kakuo ◽

Kouichi Ohmori ◽

Eiji Sasaki ◽

Michinori Togawa ◽

...

Keyword(s):

Airway Inflammation ◽

Benzimidazole Derivative ◽

Phosphodiesterase 4 ◽

Orally Active ◽

Phosphodiesterase 4 Inhibitor

Download Full-text

Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD)

Pulmonary Pharmacology & Therapeutics ◽

10.1016/s1094-5539(03)00090-7 ◽

2003 ◽

Vol 16 (6) ◽

pp. 341-347 ◽

Cited By ~ 18

Author(s):

D.C Grootendorst ◽

S.A Gauw ◽

N Benschop ◽

P.J Sterk ◽

P.S Hiemstra ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Lung Function ◽

Airway Inflammation ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

The Novel ◽

Obstructive Pulmonary Disease ◽

Phosphodiesterase 4 ◽

Phosphodiesterase 4 Inhibitor

Download Full-text